ABORN TECHNOLOGY LIMITED

Executive Summary

ABORN TECHNOLOGY LIMITED is currently dormant with minimal net assets and no active trading, resulting in a weak financial pulse but stable legal compliance. To improve financial health, the company should focus on initiating operations, strengthening capital, and maintaining diligent compliance. Without active trading or capital infusion, the company's financial outlook remains stagnant.

ABORN TECHNOLOGY LIMITED - Analysis Report

Company Number: 14177008

Analysis Date: 2025-07-20 15:00 UTC

Financial Health Assessment for ABORN TECHNOLOGY LIMITED

---

1. Financial Health Score: D

Explanation:
The company is currently classified as dormant, with minimal financial activity and very limited net assets (£1,000). This score reflects a "symptom of dormancy" — while not necessarily unhealthy, this indicates the company is not actively trading or generating revenue, which limits its financial vitality. There is no evidence of distress, but the absence of operating cash flow or earnings marks a weak financial condition from an operational perspective.

---

2. Key Vital Signs

Metric	Value	Interpretation
Net Assets	£1,000 (2024)	Extremely low capital base; minimal asset backing. Indicative of dormant company status.
Cash	£7,500 (2023)	Modest cash balance previously available; not reflected in the latest dormant accounts.
Shareholders’ Funds	£1,000 (2024)	Matches net assets; represents the equity invested, very minimal.
Account Category	Dormant	No significant trading activity reported. No revenues, expenses, or liabilities recorded.
Company Status	Active	Legally active but not trading, so "healthy" in compliance terms but inactive financially.
Filing Status	Up to date	No overdue filings; compliance "vital signs" are normal and healthy.
Directors & Control	3 Directors, PSC owns 25-50% shares	Governance structure is in place, but no operational results yet.

---

3. Diagnosis

ABORN TECHNOLOGY LIMITED is currently in a state of dormancy — akin to a patient who is alive and stable but inactive, showing no symptoms of growth or distress. The company has negligible net assets and no recorded trading activity, which means it is not generating operating cash flow or profits. This is common for very new companies or those holding assets/liabilities in abeyance without active business operations.

The financial "pulse" is weak in terms of operational output but healthy in compliance and legal terms. The company shows no signs of financial distress such as liabilities overstretching assets, cash shortages, or overdue filings. However, the absence of active trading and minimal equity suggests the company is either in a pre-trading phase or has paused operations.

---

4. Recommendations

• Activate Business Operations: To improve financial vitality, the company should initiate trading activities or revenue-generating operations. Dormancy limits growth potential and financial resilience.
• Increase Capital Base: Consider additional equity injections or funding to strengthen net asset base and support upcoming operational expenses.
• Monitor Cash Flow: Once trading begins, establish regular cash flow monitoring to avoid liquidity symptoms such as insufficient working capital.
• Maintain Compliance: Continue timely filing of accounts and confirmation statements to avoid legal penalties and reputational risks.
• Strategic Planning: Develop a clear business plan and financial forecast to transition from dormancy to active trading, improving long-term prognosis.
• Review Directors' Roles: Ensure directors are actively engaged in planning and executing the company’s business strategy.

---